Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases.

Dr. Ragan discusses X4 Pharmaceuticals, which is currently developing therapies for rare genetic diseases that result from dysfunction of the immune system and is currently undergoing a global Phase 3 trial for WHIM Syndrome and two Phase 1b trials for Waldenstrom macroglobulinemia (WM), a type of rare lymphoma, and severe congenital neutropenia (SCN).
X4 Website: https://www.x4pharma.com

X4 Twitter: https://twitter.com/x4pharma

X4 LinkedIn: https://www.linkedin.com/company/x4-pharmaceuticals

Видео Dr. Ragan Discusses X4’s Work To Advance Disease-Modifying Therapies For Rare Genetic Diseases. канала To Be Frank